| # | Drug | Count |
|---|---|---|
| 0 | ETONOGESTREL | 16 |
| 1 | LEVONORGESTREL | 3 |
| 2 | RIBAVIRIN | 3 |
| 3 | LEDIPASVIR AND SOFOSBUVIR | 2 |
| 4 | MEDROXYPROGESTERONE ACETATE | 2 |
| 5 | PEGINTERFERON ALFA-2A | 2 |
| 6 | ARIPIPRAZOLE | 1 |
| 7 | CYCLOBENZAPRINE | 1 |
| 8 | CYCLOBENZAPRINE HYDROCHLORIDE | 1 |
| 9 | EXTENDED PHENYTOIN SODIUM | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ETONOGESTREL | 16 | 0.0003 |
| 1 | CYCLOBENZAPRINE HYDROCHLORIDE | 1 | 0.0001 |
| 2 | LEDIPASVIR AND SOFOSBUVIR | 2 | 0.0001 |
| 3 | EXTENDED PHENYTOIN SODIUM | 1 | 0.0001 |
| 4 | RIBAVIRIN | 3 | 0.0000 |
| 5 | CYCLOBENZAPRINE | 1 | 0.0000 |
| 6 | LORATADINE TABLET | 1 | 0.0000 |
| 7 | LEVONORGESTREL | 3 | 0.0000 |
| 8 | LORATADINE | 1 | 0.0000 |
| 9 | ARIPIPRAZOLE | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Progestin [EPC] | 19 | 0.0001 |
| 1 | Hepatitis C Virus NS5A Inhibitor [EPC] | 2 | 0.0000 |
| 2 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 2 | 0.0000 |
| 3 | Nucleoside Analog Antiviral [EPC] | 3 | 0.0000 |
| 4 | GLP-1 Receptor Agonist [EPC] | 1 | 0.0000 |
| 5 | Atypical Antipsychotic [EPC] | 1 | 0.0000 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1 | 0.0000 |